Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
BEAM:BMV
Beam Therapeutics Inc
MX$542.00
+3.53%
(+18.46) 1D
Apr 22, 12:14:17 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for BEAM...
Mkt. cap
3.00B
Avg. vol.
6.00
Volume
0.00
52-wk high
MX$630.89
52-wk low
MX$300.57
No. of employees
511
News stories
From sources across the web
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
CEOJohn Evans
Employees511
Founded2017
Headquarters-
SectorBiotechnology
Websitebeamtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.47M
8.47M
9.70M
114.11M
Cost of goods sold
98.82M
101.76M
109.77M
99.28M
Cost of revenue
98.82M
101.76M
109.77M
99.28M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.94M
26.86M
26.74M
32.28M
Operating expense
27.94M
26.86M
26.74M
32.28M
Total operating expenses
126.76M
128.62M
136.51M
131.55M
Operating income
-119.29M
-120.15M
-126.81M
-17.44M
Other non operating income
2.26M
1.15M
8.55M
50.00K
EBT including unusual items
-109.27M
-102.29M
-112.73M
244.30M
EBT excluding unusual items
-107.16M
-106.68M
-118.26M
248.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-109.27M
-102.29M
-112.73M
244.30M
Net profit margin
-1,462.78%
-1,208.26%
-1,162.38%
214.09%
Earnings per share
-1.24
-1.00
-1.10
2.33
Interest and investment income
9.86M
12.33M
-
10.64M
Interest expense
-
-
-
-
Net interest expenses
9.86M
12.33M
-
10.64M
Depreciation and amortization charges
-
-
-
-
EBITDA
-113.76M
-114.61M
-121.25M
-11.78M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer